R. Siegrist

The Screening Compound Collection: A Key Asset for Drug Discovery.

C. Boss, T. Kimmerlin, Modest von Korff, 2017, Chimia.

Bisubstrate Inhibitors for the Enzyme Catechol O-Methyltransferase (COMT): Dramatic Effects of Ribose Modifications on Binding Affinity and Binding Mode

F. Diederich, C. Lerner, V. Gramlich, 2003 .

Evidence for the rapid conversion of stephacidin B into the electrophilic monomer avrainvillamide in cell culture.

J. Wulff, A. Myers, S. Herzon, 2007, Journal of the American Chemical Society.

Substituted pyrrolidin-2-ones: Centrally acting orexin receptor antagonists promoting sleep. Part 2.

C. Brotschi, A. Treiber, T. Sifferlen, 2015, Bioorganic & medicinal chemistry letters.

Facile Synthesis of Diastereoisomerically and Optically Pure 2‐Substituted Hexahydro‐1H‐pyrrolizin‐3‐ones

F. Diederich, P. Seiler, R. Siegrist, 2005 .

The natural product avrainvillamide binds to the oncoprotein nucleophosmin.

J. Wulff, A. Myers, R. Siegrist, 2007, Journal of the American Chemical Society.

Novel in vivo active anti-malarials based on a hydroxy-ethyl-amine scaffold.

R. de Kanter, S. Wittlin, C. Boss, 2013, Bioorganic & medicinal chemistry letters.

Discovery of a Potent, Selective T-type Calcium Channel Blocker as a Drug Candidate for the Treatment of Generalized Epilepsies.

R. de Kanter, Simon Stamm, E. A. Ertel, 2017, Journal of medicinal chemistry.